Skip to main content
Premium Trial:

Request an Annual Quote

SRI International Wins $2M from Virginia for New Research Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — SRI International will receive $2 million from the state of Virginia in the state's new $82 billion budget for the two years starting July 1 — part of the funds committed by the state in return for the research institute building its recently-opened $22 million Center for Advanced Drug Research, or CADRE, in Harrisonburg, Va.

The incentive package, announced in 2006, was tied to SRI creating at least 100 jobs by the end of 2012 at CADRE — designed to fulfill the nonprofit research and technology development institute's longtime plan to expand its biosciences division to the East Coast.

SRI was originally envisioned to receive the $22 million in installments between the 2006 and 2008 fiscal years, but has instead yet to receive $3 million of that total, as state officials struggled to plug budget shortfalls blamed on the recession.

This year, Gov. Robert McDonnell sought the full $3 million in his proposed budget for 2010-11. Both houses of the state legislature or General Assembly whittled that request down to $1 million in FY 2011, before McDonnell included another $1 million for SRI in FY 2012 as part of a package of budget amendments approved by the state House and Senate on Wednesday.

The $22 million commitment was included in the incentive package negotiated by the administration of McDonnell's predecessor, Timothy Kaine, with officials from Harrisonburg and Rockingham County.

Last November, Kaine and McDonnell led dignitaries in officially dedicating the new CADRE facility, which occupies the 40,000-square-foot first building to be completed within the Rockingham Center for Research and Technology.

CADRE aims to prevent, detect, and treat several infectious diseases by applying proteomics-based technologies to understand host-vector pathogen interactions. CADRE focuses on insect-borne viruses, respiratory and diarrheal pathogens, and diseases linked to parasitic protozoa, such as West Nile fever, dengue fever, tuberculosis, leishmaniasis, and malaria.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.